Abstract: Purpose: Prescription drug abuse has reached epidemic proportions. Nonmedical prescription opioid use carries increasingly high costs. Despite the need to cultivate efforts that are both effective and fiscally responsible, the cost-effectiveness of universal evidence-based-preventiveinterventions (EBPIs) is rarely evaluated. This study explores the performance of these programs to reduce nonmedical prescription opioid use. Methods: Sixth graders from twenty-eight rural public school districts in Iowa and Pennsylvania were blocked by size and geographic location and then randomly assigned to experimental or control conditions. Within the intervention communities, prevention teams selected a universal family and school program from a menu of EBPIs. All families were offered a family-based program in the 6th grade and received one of three school-based programs in 7th-grade. The effectiveness and costeffectiveness of each school program by itself and with an additional family-based program was assessed using propensity and marginal structural models. Results: This work demonstrates that universal school-based EBPIs can efficiently reduce nonmedical prescription opioid use. Further, findings illustrate that family-based programs may be used to enhance the cost-effectiveness of school-based programs. Conclusions: Universal EBPIs can effectively and efficiently reduce nonmedical prescription opioid use should be further considered when developing comprehensive responses to this growing national crisis .   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 Abstract Purpose: Prescription drug abuse has reached epidemic proportions. Nonmedical prescription opioid use carries increasingly high costs. Despite the need to cultivate efforts that are both effective and fiscally responsible, the cost-effectiveness of universal evidence-based-preventiveinterventions (EBPIs) is rarely evaluated. This study explores the performance of these programs to reduce nonmedical prescription opioid use.
Universal Prevention 1
Can We Build an Efficient Response to the Prescription Drug Abuse Epidemic? Assessing the Cost-Effectiveness of Universal Prevention in the PROSPER Trial
Prescription drug abuse has reached epidemic proportions in the United States with youth populations being especially vulnerable to abuse and addiction (CDC, 2011; Fischer et al., 2008; Havens, 2011; Hernandez and Nelson, 2010; Manchikanti and Singh, 2008; Maxwell, 2011; ONDCP, 2011; ) . At the center of this growing crisis are prescription opioids, with over 12 million Americans having used this pharmaceutical class for nonmedical purposes. Adolescent populations are particularly vulnerable to opioid misuse and abuse, with early initiation increasing the likelihood of future addiction (Compton and Volkow, 2006; McCabe, 2012 McCabe, , 2011 McCabe, , 2009 Meier, 2012) . In turn, these nonmedical user are estimated to cost society over $53 billion each year through their greater burden on health and service systems as well as increased rates of disability (Birnbaum et al., 2011; Coben et al., 2010; Hansen et al., 2011a; Johnston et al., 2010; SAMHSA, 2009 ).
The rise in nonmedical prescription opioid use poses a major threat to public health and many policy makers are seeking to craft practical responses (ONDCP, 2011) . Unfortunately, devising cost-effective initiatives that do not compromise pain management practices remains difficult (FDA, 2013; Fischer et al., 2008; Katz et al., 2007) . Despite development of approaches for reducing misusers' access to prescription opioids (e.g., prescription-monitoring-systems, interdiction efforts), supply side methods are often resource intensive and may be difficult to effectively deploy during times of budgetary uncertainty. Instead policymakers may wish to engage more efficient solutions (Spoth, 2011a) . For instance, demand reduction approaches that prevent nonmedical use, especially in at-risk populations, may offer a more fiscally responsible option (Catalano, 2009; Currie, 2005; O'Connell et al., 2009; Spoth, 2011b) .
One such approach is the use of universal school and family evidence-based-preventiveinterventions (EBPIs). Universal prevention programs 1 target a whole population group (e.g., school) that has not been identified based upon individual risk (e.g., prenatal care, childhood immunization; (Greenberg et al., 2001) . For instance, universal school programs are offered to all students in a school and universal family programs can be offered to all families in community with no prior screening. These programs differ from other demand reduction 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 Universal Prevention 2 approaches (e.g., public education and awareness campaigns) through their focus on reducing substance abuse risk (pro-abuse norms and expectations of use) and cultivating protective factors (refusal skills, social bonding, parental monitoring; (Hawkins et al., 1992; Kumpfer and Alvarado, 2003) . Universal EBPIs are increasingly delivered within the context of formal prevention delivery and support systems that facilitate implementation and sustainability of prevention efforts (e.g., PROSPER, Weed & Seed, Communities-that-Care, SPF-SIG, Getting-toOutcomes; (Crowley et al., 2012; Hawkins, 1992 Hawkins, , 2009 Spoth et al., 2004; Wandersman, 2000) .
Large demonstration trials, including the PROSPER study, have illustrated that EBPIs, delivered within these systems, represent a promising strategy for reducing nonmedical prescription opioid use (Aos et al., 2011 (Aos et al., , 2004 Guyll et al., 2011; Spoth et al., 2007a, Under Review; Spoth, 2006) , but relatively little work has sought to evaluate these programs' capacity to efficiently reduce nonmedical prescription opioid use in everyday contexts . This lack of evaluation has contributed to universal EBPIs being largely overlooked and underutilized in recent federal and state responses.
Limited work in this area has in part resulted from data limitations and methodological uncertainty around how to model the complex selection effects that lead to individuals receiving preventive interventions in school and family health service settings. In order to better understand the capacity of universal prevention efforts to reduce nonmedical prescription opioid use, we demonstrate a methodological approach to evaluate the cost-effectiveness of receiving multiple preventive interventions within different service settings. Specifically, through the use of propensity and marginal structural models we are able to first model who receives different programs when they are delivered in actual service contexts and then use these models to assess the incremental cost-effectiveness of programs. This differs from previous work that has assessed universal prevention largely within tightly controlled research trials that may overestimate intervention impact when programs are translated to non-research contexts. We first evaluate the cost-effectiveness of three substance abuse school-based EBPIs to prevent nonmedical prescription opioid use (Life Skills Training, All Stars & Project Alert) delivered within the PROSPER delivery and support system. Next, the impact of a combined school and family-based programming approach is assessed for each of the three school programs with a family-based EBPI . This work builds on current understanding of universal prevention programs' effectiveness and provides insight into their cost-effectiveness. Through   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 Universal Prevention 3 these analyses we gauge the real-world performance of universal programs in order to identify cost-effective approaches for reducing this growing epidemic.
Methods
In order to evaluate the cost-effectiveness of the four universal EBPIs in actual service settings, propensity and marginal structural models were fitted within a cost-effectiveness analysis of the PROSPER dissemination trial.
Sample
The National Institute of Health funded PROSPER dissemination trial included 14 communities in Iowa and 14 communities in Pennsylvania based upon four criteria that included
(1) school district enrollment between 1,301 and 5,200 students, (2) at least 15% of families eligible for reduced cost lunch, (3) maximum of 50% of the adult population employed at or attending a college or university, and (4) the community could not be involved in other university-affiliated, youth-focused prevention initiatives. Communities were matched by geographic location and size; each pair of communities was randomized into intervention and control conditions by the principal investigators (Spoth et al., 2007b (Spoth et al., , 2004 . Approximately half the sample comprised the control condition (N=5,292; Figure 1 ). Within the intervention communities, local prevention teams led by local cooperative extension agents and school officials selected a universal family and school program from a menu of EBPIs (Spoth et al., 2004) . All families in intervention communities were offered the Strengthening Families 10-14 program (SFP:10-14) in the 6 th grade, but not all families enrolled (N=827). In addition, all youth in the intervention communities (N=5,026) received one of three school-based substance abuse programs in the 7th grade (All Stars (N=1,936), Life Skills Training (N=1,166) and Project Alert (N=1,924). Thus while the PROSPER participants were randomized to either intervention or control groups, the type of school intervention they received and whether they attended the family program was not randomized. Additional information about the different EBPIs may be found in Appendix 1. Program adherence was high for both school and family programs (M = 90%; see (Spoth et al., 2011) . The participating universities' IRBs approved the study procedures before recruitment began.
Measurement
Estimates of Program Cost. The costs of the evidence-based prevention programs delivered within the PROSPER dissemination trial were estimated in an earlier prospective five- 
Analytic Approach
As described above, PROPSER participants were randomized at the community level to treatment groups. However, which school-based EBPI they received was chosen by each community's team and families chose whether to attend the evening family program. Thus, in order to estimate the benefits of receiving the different school programs as well as the benefits of receiving the school and family programs together, a multi-step analytic framework was employed. This included (1) estimation of participants' propensity to receive different programs, (2) fitting marginal structural models to estimate the impact of receiving different programs on ever using prescription opioids for non-medical purposes, (3) calculation of incremental costeffectiveness ratios, and (4) threshold analyses to assess whether a program represents an efficient societal investment.
Propensity & Marginal Structural Models. Propensity and marginal structural models are well-established analytic tools used to improve causal inference when using observational data (Robins et al., 2000; Rosenbaum and Rubin, 1983) . Propensity models were employed here to estimate the probability that an individual will receive each of the programs based upon a variety of prespecified covariates (See Appendix 1). Within this evaluation, we estimated individuals'
probabilities of receiving seven possible outcomes (i.e., participants' propensity to receive either no program, one of the three school programs, or one of the three school programs and the family program). These probabilities were then transformed into inverse probability weightswhich may be used similarly to survey weights-to balance the different possible forms of Universal Prevention 5 treatment receipt on the confounders included in the propensity model. These weights were used to adjust marginal structural models, to estimate the effectiveness of the programs to reduce nonmedical prescription opioid use. PROC GLIMMIX was implemented to fit multi-level logistic models that accounted for the nested structure of the trial (i.e., participant nested within school, (Littell, 2006) Further description of the covariates that were included in the propensity models and how the propensity and marginal structural models were implemented may be accessed in Appendix 1 & 2.
Incremental Cost-Effectiveness Analysis. Next, the incremental cost-effectiveness ratios (ICERs) for different levels of program receipt were estimated (Figure 1 ). The numerator of an ICER is the difference in costs for treatment outcomes (e.g., school program versus control). The denominator of the ICER is the difference in the average effect sizes of the two interventions.
ICERs were calculated for each program combination that significantly reduced nonmedical use compared to the control condition (at the p ≤ .05 level). Statistical bootstrap techniques were employed to construct 95% confidence intervals around each ICER (using 1000 replications; (Briggs et al., 1997) Threshold Analysis. Each ICER was considered relative to the societal cost of allowing youth to engage in nonmedical prescription opioid use (i.e., Willingness-to-Pay). Recent analyses have placed the cost of nonmedical prescription opioid use at between $53.2 and $55.7 billion annually. An estimated 12.5 million individuals reported using prescription opioids for non-medical purposes (Birnbaum et al., 2011; Hansen et al., 2011b) . This translates into an approximate average societal cost of $4,132 per nonmedical opioid user per year. The average course of nonmedical use for this age group (late adolescence and early adulthood) is 2.17 years (Catalano et al., 2011) . Based upon this previous work, it can be estimated that youth who engage in nonmedical prescription opioid use cost society approximately $8,966 per year. When discounted across the six years of program follow-up within the PROSPER trial, at a standard rate of 3%, this figure rounds to $7,500 (Russell et al., 1996) . This estimate serves as the basis for a Willingness-to-Pay (WTP) threshold, where allocating less than $7,500 (i.e., the estimated societal cost of an adolescent or young adult nonmedical opioid user) to preventing a single case of nonmedical use is an economically efficient decision. In other words, if the 95% confidence interval of this ICER falls below this societal WTP, one could make a case that it is more Universal Prevention 6 efficient to allocate the resources toward prevention services versus doing nothing and allowing the case of nonmedical opioid use to take its course.
Results
Here we consider the results of the effectiveness, cost-effectiveness, and threshold analyses in order to ascertain the impact and efficiency of the three school programs with and without the family program compared to those youth in the control group. As presented in Table   1 , there is increasing lifetime use of prescription opioids across adolescence with over 25% of seniors ever having used a prescription opioid that was not prescribed by a doctor.
Effectiveness Analyses. The effectiveness of the different PROSPER program combinations were evaluated to assess the impact of the school and family program, compared to the control condition (Table 2; Cost-Effectiveness Analysis. Table 2 provides ICERs (i.e., the difference of the average of the predicted probabilities for the treatment and comparison groups) and their standard errors.
The Life Skills Training program alone compared to the control group had the lowest ICER and thus is the program option with the greatest relative productive efficiency (ICER = $613 When compared to each other, where the Life Skills and SFP:10-14 combination has a lower ICER than the All Stars and SFP:10-14 combination, we can infer that the most efficient allocation of societal money would be to invest in the combined delivery of the Life Skills and SFP:10-14 programs.
Discussion
Policy-makers and community leaders are actively searching for efficient responses to the growing prescription drug epidemic (FDA, 2013; Maxwell, 2011; ONDCP, 2011) . In particular, due to prescription opioids' growing popularity among adolescents and young adults, it is vital that any coordinated strategy meets the needs of this vulnerable population. Without an effective approach for curbing nonmedical use, Federal agencies are being forced to restrict access to prescription opioids -at the cost of greater burden on suffering patients (Volkow, 2011) . The present study builds on earlier reports universal EBPIs implemented effectiveness and demonstrates that universal school-based EBPIs are capable of reducing nonmedical prescription opioid use by youth in a cost-effective manner and may supplement costly approaches to monitor and restrict access . Further, this evaluation reveals the potential of family-based EBPIs during early adolescence to enhance the efficiency of schoolbased programs. Thus, by employing propensity and marginal structural models we are able to leverage the unique data within the PROSPER trial to compare the impact of the different school programs and family programs.
In light of these findings, decision makers seeking to craft comprehensive responses to prescription drug abuse may wish to consider the potential value of broader evidence-based drug use prevention efforts that nurture healthy cognitions and behaviors by parents and youth. In particular, current estimates illustrate that nonmedical use is continuing to rise despite early efforts to stem the tide of abuse and now may be time to engage new options (ONDCP, 2011) .
This approach may reduce demand for tertiary approaches which while cost-effective may garner less public support (e.g., soboxone and methadone maintenance; Polsky et al., 2010) .
By employing the analytic approach described above we can better understand universal prevention's cost-effectiveness, and these specific analyses reveal the value of intervening across This evaluation sought to understand the cost-effectiveness of universal EBPIs specifically on preventing prescription opioid abuse. This is likely a dramatic underestimate of the total societal value from universal programs that are known to not only prevent other forms of substance abuse (e.g., alcohol, tobacco, methamphetamines; Guyll et al., 2011; Spoth et al., 2008b ) but a variety of delinquent behaviors linked to long-term criminality and increased use of social service systems (Aos et al., 2011) . Nevertheless, compared to approaches that aim to reduce nonmedical use that is already occurring (e.g., treatment), a prevention-oriented approach to nonmedical use may be especially well-suited for society's current needs. For instance, opioid addiction is generally considered a chronic illness and requires costly treatments that quickly overburden community service systems (McLellan, 2000) . Consequently, even small reductions in those ever requiring treatment can save substantial public monies. Alternately, because of the important role of prescription opioids in pain management, interdiction and enforcement efforts may harm or stigmatize those with legitimate medical need. Universal prevention efforts that serve entire populations, targeting risk and protective factors for nonmedical use, can offer society a means of protecting youth populations from nonmedical use while allowing those who are suffering access to the best possible therapies.
Limitations
A substantial body of literature has illustrated that-across settings-adequate capacity is essential for high-quality implementation of evidence-based programs and practices (e.g., hospital, school, clinical). It is increasingly advised that large-scale delivery of such efforts not be attempted without formal capacity building (Samet, 2001; Spoth et al., 2004 ; Wandersman ,   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 Universal Prevention 9 2000). In particular, delivery of universal EBPIs without such support can lead to diminished impact and lower levels of program efficiency (Spoth et al., 2004) . In response, substance abuse researchers working with youth populations have developed multiple support systems that can effectively cultivate and maintain such capacity (Dunworth et al., 1999; Hawkins, 1992; Spoth et al., 2004) . To maximize the generalizability of these estimates, this study considers program impact when delivered within such a system (i.e., PROSPER; (Spoth et al., 2004) . Thus these estimates are not applicable to attempts to deliver universal EBPIs without such support systems as both the costs and effectiveness are likely to differ. 
Conclusion
With this work we seek to draw attention to the potential value of universal school-and family-based EBPIs as part of an efficient response to the growing prescription drug epidemic.
Given the rapid changes in health care policy and the opportunities provided for prevention and health promotion services in The Affordable Care Act, the use of community-based prevention The PROSPER delivery and support system links stakeholders from the state and local cooperative extension service (CES) and local public school systems for the purpose of implementing school-and family-based preventive interventions (Spoth et al., 2004 ). An embedded CES agent and a school official comprise the core of community prevention teams that involve multiple members representing various community interests. The local teams are supported by prevention coordinators in the CES and by university prevention teams (for a review, see Spoth et al., 2004) . The teams each select from a menu of school and family evidence-based programs and offer those programs to youth and families within the community.
Within the PROSPER dissemination trial three school programs were delivered (each community only delivers one of these programs): Life Skills Training, Project Alert and All 
School-Level Confounders
School Uses a Structured Curriculum · The school's use of structured curriculum to teach skills and change norms for behavior.
Percentage on Free Lunch · What percentage of your school's total student population is eligible for free or reduced cost lunches?

Parent Outreach · In the past year, has your school made an effort to increase parental involvement in the school
Community Pressure · There is pressure in the community to change things in the school.
Teacher Resistance · Teachers in this school resist changes imposed from outside the school.
Involvement of Agency · Agency Involvement in Youth Coalition
School Attitude to Prevention · The degree to which the school's alcohol and tobacco policies emphasize prevention.
District Attitude to Prevention · Principal's perception of district level attitudes toward prevention.
Number of Teachers in School · How many full-time classroom teachers does your school have?
Team-Level Confounders
Extension 
Appendix 2: Statistical Methods
In order to estimate the benefits of receiving the different programs delivered within PROSPER as well as the benefits of receiving multiple programs, a five-step analytic framework is employed (see Coffman et al., 2011) . These steps include (1) defining the causal effects, (2) estimation of participant propensity to receive different program levels, (3) calculation and application of inverse probability weights to account for selection effects, (4) evaluation of the balance between program levels, and (5) outcome analyses of the impact of different program levels on ever using prescription opioids for nonmedical purposes.
Overall missingness was low and participation was similar to comparable longitudinal trials. The average missingness of an item was about 10.0% (SD=9.7%). Previous evaluations of PROSPER explored the study's missingness and found no evidence of threats to internal validity from differential sample attrition at grade 12. Multiple imputation was used to account for any missing data (STATA MI mvn) [50] [51] [52] This procedure uses an iterative Markov chain Monte Carlo (MCMC) method to impute missing values using a joint modeling approach under a multivariate normal model. The mvn approach uses estimates from the EM algorithm as starting values for the MCMC procedure. Twenty imputations were obtained and each imputation was drawn after a burn-in period of 100 iterations. The mvn procedure applied to handle missing data allowed for complete data analysis for both the propensity models and the outcome analysis.
Defining Casual Effects. The causal effects are defined using marginal structural models, which are models for potential outcomes. 4.
5.
6.
7.
8.
9.
10.
11.
12.
Becuase marginal structural models are models for the potential outcomes and not all the potential outcomes are observed, they cannot be estimated without further assumptions.
Specifically, to estimate these models the assumption is made that there are no unaccounted for confounders influencing receipt of either the school or family programs, and thus, the causal effects are estimated using inverse probability weighted models for the observed outcomes.
Propensity Score Estimation Process. Within this project, two sets of propensity scores are estimated. Using multinomial logistic models, the propensity a person receives-(1) no program, (2) the school program, and (3) the school and family program together, is estimated using a multinomial logistic regression. Because communities voluntarily picked one of the three offered school programs, a second set of propensity scores is then estimated for receipt of the different school-based programs also using a multinomial regression. 54 Both of these analyses were carried out using the GLIMMIX procedure in SAS 9.1 31 that allows for specification of a link function, which for multinomial logistic and count data estimated here is log. This procedure also estimates error terms for non-normally distributed dependent variables. The propensity models to estimate these scores employ confounders across participant, organizational, infrastructure and community levels to predict program receipt and meet the stable unit treatment value assumption (SUTVA; described above). In order to test whether the logit link was appropriate, the Hinkley test was employed. 55 This test includes the logit propensity score squared as a covariate in the propensity model to test whether it is significantly related to the treatment condition in the presence of the other confounders.
In this study, propensity models were estimated for both the probability of participants being in the different school programs and the family program. Both models passed the Hinkley's test described above and were found to have suitable overlap. 55 Inverse probability weights were calculated and further diagnostics of balance were conducted. Unweighted and weighted standardized mean differences (SMD) between the control and treatment groups were calculated for each confounder in both propensity models. 30 Weighting generally lowered or maintained the SMDs of each confounder and no confounders had an absolute SMD above .2 when weighted, which is generally considered to be small. 56 Finding a small effect size across the confounders included in the model indicates that the different treatment groups are balanced and increases confidence in causal inferences. Life Skills, β 5 is the effect of receiving SFP:10-14 in addition to All Stars, and β 6 is the effect of receiving SFP:10-14 in addition to Project Alert. Thus the IPWs are employed to meet the assumption that no confounders are unaccounted for in the outcome analysis; these β's , which correspond to those in the marginal structural models, can be interpreted as causal effects.
The outcome model, which is fit using the PROC GLIMMIX procedure, includes a binary outcome measure of whether youth had ever misused prescription opioids. PROC GLIMMIX allows a weighting function that may be employed to include the IPWs in the model and provides robust standard errors. This procedure allows for the inclusion of the two-level nested design of the model, with individuals nested within communities. Outcomes and estimation 17a For each primary and secondary outcome, results for each group, and the estimated effect size and its precision (such as 95% confidence interval)
8 Table 2 17b For binary outcomes, presentation of both absolute and relative effect sizes is recommended Table 2 Ancillary analyses
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Results of any other analyses performed, including subgroup analyses and adjusted analyses, distinguishing pre-specified from exploratory 8-9, Table 2 Harms 
